Back
Baxter International 10K Form
Sell
48
BAX
Baxter International
Last Price:
$33.99
Seasonality Move:
2.05%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-02 | 10Q | BAX/Baxter International Quarterly |
2024-02-08 | 10K | BAX/Baxter International Annual |
2023-11-02 | 10Q | BAX/Baxter International Quarterly |
2023-07-27 | 10Q | BAX/Baxter International Quarterly |
2023-04-27 | 10Q | BAX/Baxter International Quarterly |
2023-02-09 | 10K | BAX/Baxter International Annual |
Receive BAX News And Ratings
See the #1 stock for the next 7 days that we like better than BAX
BAX Financial Statistics
Sales & Book Value
Annual Sales: | $10.6B |
---|---|
Cash Flow: | $351M |
Price / Cash Flow: | 31.56 |
Annual Sales: | $13.63 |
Price / Book: | 2.54 |
Profitability
EPS (TTM): | -1.28000 |
---|---|
Net Income (TTM): | $-649M |
Gross Margin: | $4B |
Return on Equity: | -8.24% |
Return on Assets: | -2.41% |
Baxter International Earnings Forecast
Key Baxter International Financial Ratios
-
The Gross Profit Margin over the past 41 years for BAX is 37.46%.
-
The Selling, General & Administrative Expenses for BAX have been equal to 27.90% of Gross Profit Margin.
-
The Research & Development expenses have been 5.55% of Revenue.
-
The Net Earning history of BAX is -6.10% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 24 years.
Baxter International Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | BAX |
CUSIP: | 071813 |
Website: | baxter.com |
Debt
Debt-to-Equity Ratio: | 1.88 |
---|---|
Current Ratio: | 1.36 |
Quick Ratio: | 0.54 |
Price-to-Earnings
Trailing P/E Ratio: | 6.37 |
---|---|
Forward P/E Ratio: | 12.63 |
BAX Technical Analysis vs Fundamental Analysis
Sell
48
Baxter International (BAX)
is a Sell
Is Baxter International a Buy or a Sell?
-
Baxter International stock is rated a SellThe current Baxter International [BAX] share price is $34.51. The Score for BAX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.